Reduction in Aβ-induced cell death in the hippocampus of 17β-estradiol-treated female rats is associated with an increase in IGF-I signaling and somatostatinergic tone

作者: Aránzazu Perianes-Cachero , Sandra Canelles , David Aguado-Llera , Laura M. Frago , María Val Toledo-Lobo

DOI: 10.1111/JNC.13381

关键词:

摘要: Several studies indicate that 17β-estradiol (E2) protects against amyloid β-peptide (Aβ)-induced cell death and activates factors associated with learning memory, a function involving the hippocampal somatostatinergic system. As alterations in somatostatin have been demonstrated Alzheimer's disease, we examined whether E2 prevents changes system induced by Aβ25-35 death, as well possible involvement of leptin insulin-like growth factor (IGF)-I signaling. We also measured levels Aβ proteases neprilysin insulin-degrading-enzyme. Co-administration reduced both its addition to preventing Aβ-induced depletion some parameters. Activation IGF-I pathways increased after co-administration, this correlated Changes components were inversely related death. Moreover, only plus E2-treated rats prevented insulin-degrading-enzyme reduction. Our results suggest E2-induced reduction is lower levels, probably because modulation proteases. asked how β-amyloid co-administration Aβ-produced (SRIF) an IGF-I-mediated mechanism, being protective effect increase SRIF CREB, cAMP response element-binding protein; IGF-I, factor-I; STAT3, signal transducer activator transcription-3.

参考文章(79)
Amanda L. Wright, Raphael Zinn, Barbara Hohensinn, Lyndsey M. Konen, Sarah B. Beynon, Richard P. Tan, Ian A. Clark, Andrea Abdipranoto, Bryce Vissel, Neuroinflammation and Neuronal Loss Precede Aβ Plaque Deposition in the hAPP-J20 Mouse Model of Alzheimer’s Disease PLoS ONE. ,vol. 8, pp. e59586- 14 ,(2013) , 10.1371/JOURNAL.PONE.0059586
Lan Zhang, Huiying Zhao, Xiangjian Zhang, Linyu Chen, Xumeng Zhao, Xue Bai, Jian Zhang, Nobiletin protects against cerebral ischemia via activating the p-Akt, p-CREB, BDNF and Bcl-2 pathway and ameliorating BBB permeability in rat. Brain Research Bulletin. ,vol. 96, pp. 45- 53 ,(2013) , 10.1016/J.BRAINRESBULL.2013.04.009
J.-L. Martin, M.-F. Chesselet, K. Raynor, C. Gonzales, T. Reisine, Differential distribution of somatostatin receptor subtypes in rat brain revealed by newly developed somatostatin analogs. Neuroscience. ,vol. 41, pp. 581- 593 ,(1991) , 10.1016/0306-4522(91)90351-N
Marc R. Montminy, Louise M. Bilezikjian, Binding of a nuclear protein to the cyclic-AMP response element of the somatostatin gene. Nature. ,vol. 328, pp. 175- 178 ,(1987) , 10.1038/328175A0
Jill M. Daniel, Christine F. Witty, Shaefali P. Rodgers, Long-term consequences of estrogens administered in midlife on female cognitive aging. Hormones and Behavior. ,vol. 74, pp. 77- 85 ,(2015) , 10.1016/J.YHBEH.2015.04.012
Nobuko Kimura, Sanae Tomizawa, Kazuko Nakata Arai, R. Yoshiyuki Osamura, Narimichi Kimura, Characterization of 5′-Flanking Region of Rat Somatostatin Receptor sst2 Gene: Transcriptional Regulatory Elements and Activation by Pitx1 and Estrogen1 Endocrinology. ,vol. 142, pp. 1427- 1441 ,(2001) , 10.1210/ENDO.142.4.8098
Emma Burgos-Ramos, Gabriel Á Martos-Moreno, Manuela G. López, Rosario Herranz, David Aguado-Llera, Javier Egea, Diana Frechilla, Edurne Cenarruzabeitia, Rafael León, Eduardo Arilla-Ferreiro, Jesús Argente, Vicente Barrios, The N‐terminal tripeptide of insulin‐like growth factor‐I protects against β‐amyloid‐induced somatostatin depletion by calcium and glycogen synthase kinase 3β modulation Journal of Neurochemistry. ,vol. 109, pp. 360- 370 ,(2009) , 10.1111/J.1471-4159.2009.05980.X
T Kosaka, J -Y Wu, R Benoit, None, GABAergic neurons containing somatostatin-like immunoreactivity in the rat hippocampus and dentate gyrus Experimental Brain Research. ,vol. 71, pp. 388- 398 ,(1988) , 10.1007/BF00247498